Monopril and Neoplasm malignant - a phase IV clinical study of FDA data

Summary:

Neoplasm malignant is reported as a side effect among people who take Monopril (fosinopril sodium), especially for people who are female, 60+ old, also take Glucotrol Xl, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Neoplasm malignant when taking Monopril. It is created by eHealthMe based on reports of 5,820 people who have side effects when taking Monopril from the FDA, and is updated regularly.

What is Monopril?

Monopril has active ingredients of fosinopril sodium. It is often used in high blood pressure. eHealthMe is studying from 5,910 Monopril users. Check the latest studies of Monopril.

What is Neoplasm malignant?

Neoplasm malignant (cancer tumour) is found to be associated with 1,543 drugs and 1,261 conditions by eHealthMe. Check the latest studies of Neoplasm malignant.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

5,820 people reported to have side effects when taking Monopril.
Among them, 15 people (0.26%) have Neoplasm malignant.

Could Monopril cause Neoplasm malignant?

Among these 15 people:

What is the gender of people who have Neoplasm malignant when taking Monopril? *

female: 53.33 %
male: 46.67 %

What is the age of people who have Neoplasm malignant when taking Monopril? *

What are other drugs people take besides Monopril? *

What are other side effects people have besides Neoplasm malignant? *

Fatigue (feeling of tiredness): 10 people, 66.67%
Rashes (redness): 8 people, 53.33%
Malaise (a feeling of general discomfort or uneasiness): 8 people, 53.33%
Weight Decreased: 7 people, 46.67%
Hyperplasia (enlargement of an organ or tissue): 7 people, 46.67%
Fall: 7 people, 46.67%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 46.67%
Gingival Bleeding (bleeding gums): 7 people, 46.67%
Haematuria (presence of blood in urine): 7 people, 46.67%
Head Injury: 7 people, 46.67%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 7 people, 46.67%
Rheumatoid Vasculitis (inflammation of veins with painful joints and morning stiffness): 3 people, 20.00%
Polyneuropathy (neurological disorder that occurs when many peripheral nerves throughout the body malfunction simultaneously): 3 people, 20.00%
Insomnia (sleeplessness): 3 people, 20.00%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 6.67%
Osteoarthritis (a joint disease caused by cartilage loss in a joint): 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Monopril and have Neoplasm malignant?

- Check whether Neoplasm malignant is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Monopril:

Monopril (5,910 reports)

Browse all side effects of Monopril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Neoplasm malignant:

Neoplasm malignant (1,543 drugs)

Browse all the conditions that are associated with Neoplasm malignant:

Neoplasm malignant (1,261 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fosinopril sodium (the active ingredients of Monopril) and Monopril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.